Apollo Hospitals Enterprise Ltd.

BSE: 508869 | NSE: APOLLOHOSP
Large Cap | Hospital & Healthcare Services
6941.15
23.85 (0.34%)
< Home < Back

Apollo Hospitals introduces treatment of uterine fibroids

Date: 03-02-2012

Apollo Hospitals has rolled out an MRI-guided high intensity focused ultrasound solution from Philips Healthcare to offer non-invasive treatment of uterine fibroids in women. As per the traditional treatment, women have to undergo surgery and a long road to recovery, which takes up several months to recover. The solution is currently available in four Apollo hospitals - in Chennai, Delhi, Bangalore and Hyderabad and it plans to expand to other centers as well.

MRI-guided ultrasound solution will be helpful as it involves no radiation, no scar, no anesthesia, recovery time of just a day, more precise magnetic resonance image guided treatment. Traditional surgery costs Rs 40,000-60,000 at Apollo, the new solution will cost Rs 70,000-90,000. The cost of the Philips machine imported from Helsinki is Rs 5 crore.

Apollo Hospitals, is the leading private sector healthcare provider in Asia and owns and manages a network of speciality hospitals and clinics, a chain of Pharmacy retail outlets across the country, and provides Consultancy Services for commissioning and managing the Speciality Hospitals.